1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PFN2 CTRPv2 pan-cancer AAC -0.19 8e-06
mRNA MMP17 CTRPv2 pan-cancer AAC 0.2 8e-06
mRNA PLEK2 CTRPv2 pan-cancer AAC 0.19 9e-06
mRNA OR2B11 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA PRAM1 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA PHLPP2 CTRPv2 pan-cancer AAC -0.16 9e-06
mRNA DPP7 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA ADAP1 CTRPv2 pan-cancer AAC 0.18 9e-06
mRNA ITGA6 CTRPv2 pan-cancer AAC 0.19 9e-06
mRNA EPHA1 CTRPv2 pan-cancer AAC 0.18 1e-05
Download CSV